Pacira BioSciences, Inc.

PCRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$147,589$300,484$283,610$276,774
Short-Term Investments$98,745$145,380$210,016$207,841
Receivables$115,468$114,367$104,745$113,304
Inventory$157,680$148,163$133,754$125,282
Other Curr. Assets$43,269$37,219$27,837$21,929
Total Curr. Assets$562,751$745,613$759,962$745,130
Property Plant & Equip (Net)$191,654$201,706$213,179$216,391
Goodwill$20,317$20,300$21,520$0
Intangibles$382,396$422,563$434,969$425,970
Long-Term Investments$0$18,810$0$0
Tax Assets$120,188$128,270$129,008$130,376
Other NC Assets$20,271$0$28,031$35,649
Total NC Assets$734,826$791,649$826,707$808,386
Other Assets$0$0$0$0
Total Assets$1,297,577$1,537,262$1,586,669$1,553,516
Liabilities
Payables$17,687$30,124$23,172$19,133
Short-Term Debt$9,748$202,397$202,086$201,776
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$79,043$0$0$28,811
Total Curr. Liab.$107,078$313,164$314,732$309,920
LT Debt$376,721$378,095$381,290$383,545
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$4,587$4,583$6,996$0
Other NC Liab.$43,138$42,362$41,432$37,058
Total NC Liab.$463,285$466,331$473,396$465,248
Other Liabilities$0$0$0$0
Cap. Leases$0$50,911$53,083$53,532
Total Liabilities$570,363$779,495$788,128$775,168
Equity
Pref Stock$0$0$0$0
Common Stock$48$48$47$47
Retained Earnings-$200,959-$206,391-$201,544-$206,356
AOCI$4,123$4,062$1,351$343
Other Equity$0$0$0$0
Total Equity$727,214$757,767$798,541$778,348
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,297,577$1,537,262$1,586,669$1,553,516
Net Debt$238,880$280,008$299,766$308,547